Silver Book publication

Silver Book: Valve Disease Volume

As many as 11.6 million Americans in the U.S. have heart valve disease (HVD), and more than 1 in 10 adults ages 75 and older have HVD. Thankfully, the HVD field has experienced tremendous advances in improving survival, recovery, and quality of life for patients.

5 Matching Facts

Search matching Facts:
No results to display
    • The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.
       
    • The volume of mitral valve surgical procedures increased approximately 8.3% from 2010 to 2013.
       
    • The annual total incremental per patient health care expenditures for heart valve disease patients ranged from $1,755 in 1996 to $12,789 in 2011.
       
    • Pulmonary hypertension is a complication in at least 23% of patients with significant mitral regurgitation due to flail leaflet, and approximately doubles the risk of death and heart failure after diagnosis.
       
    • Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.